Everest Medicines Announces New Drug Application Acceptance by China NMPA for Nefecon for the Treatment of Primary IgA Nephropathy
-- NDA acceptance takes Everest closer to making this first-in-disease treatment available for primary IgAN patients in China -- China is home to the largest patient base for IgAN with estimated 5 million people with the disease and currently there is no approved treatment in the country -- Nefecon is approved in the U.S. and E.U., and received Breakthrough Therapy...
Innovent Announces First Participant Dosed in a Phase 3 Clinical Study (GLORY-1) of Mazdutide (IBI362) in Chinese Adults with Overweight or Obesity
ROCKVILLE, Md. and SUZHOU, China, Nov. 15, 2022 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, today announced that the first participant has been successfully dosed in a phase 3 clinical trial (GLORY-1) of mazdutide (Innovent...
First “Global State of Digital Health Report” Tapping into 200 Million Data Points Examining over 12,000 Digital Health Ventures Released At HLTH
Global Digital Health Intelligence Company Galen Growth and Integrated Marketing Agency FINN Partners Release Breaking Report for Free Download Report Will Guide C-Suite Entrepreneurs and Private Equity Investment Strategies NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Galen Growth, the leading digital health, data-driven market intelligence company, and FINN Partners, an independent global integrated marketing...
LumiraDx Continues Commercial Expansion of its Rapid Microfluidic Immunoassay HbA1c Test
Now Available in Europe, parts of the Middle East, Asia, Latin America, and Africa Early customers include GP offices and other community-based healthcare settings Latest figures, released as part of World Diabetes Day, reveal that 1 in 10 adults are now living with diabetes and nearly half are undiagnosed1 The LumiraDx HbA1c test is designed to address...
Shiang Ding Targets US Market With Healthy Herbal Beverage Alternatives
TAIPEI, Nov. 14, 2022 /PRNewswire/ -- Shiang Ding Food Co. (Shiang Ding), one of Taiwan's premier food wholesalers, announced new plans to expand access to healthy, herbal tea and coffee alternatives in the US market via its Tang Ding brand of brown sugar tea bricks. This announcement comes amid an ever-growing interest in complementary and alternative medicinal solutions in...
AIRS Medical showcases award-winning MRI enhancement AI solution at RSNA 2022
SEOUL, South Korea, Nov. 14, 2022 /PRNewswire/ -- AIRS Medical, Inc., a leading medical AI solution provider, announced its participation in the 108th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA 2022), the world's leading annual imaging forum at McCormick Place in Chicago held from November 27 to 30th. At RSNA booth #4744, AIRS Medical...
The World’s First ETa-specific Monoclonal Antibody: Gmax Biopharm’s GMA131 Approved by the US FDA for Clinical Study on (DKD) Diabetic Kidney Disease
HANGZHOU, China, Nov. 14, 2022 /PRNewswire/ -- Gmax Biopharm LLC. announced today that its application of investigation of New Drug (IND) for GMA131 injection, the first global ETa-specific monoclonal antibody, was approved by the US FDA on Nov 11, 2022 for clinical study on diabetic kidney disease (DKD). Dr. Shuqian Jing, Founder and Chairman of Gmax Biopharm, said, "GMA131...
NuraLogix Researchers Announce the Capability to Assess Type 2 Diabetes and Blood Biomarker Health Issues Using Any Video-Enabled Device
Facial blood flow patterns can predict a person's risk of pre-diabetes in just 30 seconds LAS VEGAS, Nov. 14, 2022 /PRNewswire/ -- Researchers at NuraLogix, a global pioneer of contactless health monitoring through its patented Transdermal Optical Imaging (TOI™) technology, has announced that it is adding the ability to perform metabolic and blood biomarker health risk assessments for various...
EMOTIV Partners with X-trodes to Launch New Medical-Grade, At-Home Solution for Brain Monitoring Research
Wearable Electrode Patches Provide Unprecedented Accuracy for Researchers Measuring Brain and Physiological Signals Outside the Lab, Expanding Possibilities for Real-World Clinical Studies SAN FRANCISCO and HERZLIYA, Israel, Nov. 14, 2022 /PRNewswire/ -- EMOTIV, a bioinformatics company advancing understanding of the human brain using electroencephalography (EEG), and X-trodes, a company bringing wireless medical-grade monitoring solutions to the home environment,...
Meihua International Medical Technologies Co., Limited Reports Unaudited 2022 First Half Financial Results
YANGZHOU, China, Nov. 14, 2022 /PRNewswire/ -- Meihua International Medical Technologies Co., Limited ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries in China, today reported its unaudited financial results for the six months ended June 30, 2022. First Half 2022 Unaudited Financial Highlights ...
